1 tracked superinvestor hold ORUKA THERAPEUTICS INC (ORKA), worth $131M combined, led by Andreas Halvorsen. Smart money is holding ORKA as of the latest 13F filings.
Current price
$88.27
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Market cap
$2.3B
P/E
-33.83
Div yield
0.0%
Revenue YoY
0.0%
Analyst target
$153
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
1
tracked 13F / N-PORT funds
Combined value
$131M
disclosed long exposure
Tier-1 conviction
1
concentrated holders
Net this quarter
0
0 buying · 0 selling
Smart money is holding ORKA steady this quarter — buys and sells are balanced.
ORUKA THERAPEUTICS INC (ORKA) is held by 1 tracked funds worth $131M combined, 1 of them concentrated Tier-1 managers whose positions carry real conviction.
The largest position belongs to Andreas Halvorsen at 0.4% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
Tracked holders were largely static this quarter — no new opens, adds or trims of size — suggesting the position is being held rather than actively traded.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Held | 0.4% | $131M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own ORKA?
1 tracked funds hold ORUKA THERAPEUTICS INC (ORKA), the largest being Andreas Halvorsen (Viking Global Investors) at 0.4% of its 13F portfolio. 1 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling ORKA?
In the most recent 13F quarter, 0 tracked funds added or opened ORKA and 0 trimmed it.
How much ORKA do tracked funds hold?
Combined disclosed long exposure to ORKA across tracked superinvestors is $131M as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.